Disease Overview：Bile reflux gastritis（BRG）
Bile reflux gastritis is a chronic inflammatory condition of the gastric mucosa caused by pathological retrograde flow of duodenal contents—including bile acids, pancreatic enzymes, and intestinal bacteria—into the stomach. Unlike acid reflux, this disorder involves alkaline bile rather than gastric acid, leading to mucosal injury, oxidative stress, and impaired gastric barrier function. Symptoms commonly include persistent epigastric burning, nausea, bilious vomiting, early satiety, and postprandial discomfort; endoscopic findings may reveal erythema, erosions, or atrophic changes. Diagnosis relies on upper gastrointestinal endoscopy with biopsy, 24-hour intragastric bile acid monitoring (e.g., Bilitec probe), and exclusion of confounding conditions such as H. pylori infection or autoimmune gastritis. Management emphasizes bile acid sequestration (e.g., cholestyramine), prokinetic agents, mucosal protectants, and, in refractory cases, surgical interventions like Roux-en-Y diversion.
China offers distinct advantages for international patients seeking evidence-based care: leading digestive disease centers—such as Beijing Friendship Hospital and Shanghai Renji Hospital—house nationally accredited GI motility laboratories and perform over 10,000 therapeutic endoscopies annually using high-definition magnification endoscopy and real-time pH/bile monitoring. Clinical outcomes reflect strong efficacy: published cohort studies report ≥85% symptom resolution at 6 months with multimodal medical therapy. Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising standards—accredited hospitals adhere to ISO 9001 and JCI-aligned protocols. As a dedicated medical tourism agency, we streamline access for international patients: arranging consultations with certified gastroenterologists, coordinating diagnostic workups and follow-up care, providing itemized, transparent pricing in advance, and offering end-to-end support—from visa assistance and accommodation to multilingual clinical coordination and post-discharge telehealth follow-up.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Bile Reflux Gastritis (Digestive Medicine)
Non-Surgical / Conservative Management
*Target Criteria:* Mild–moderate symptoms (epigastric burning, nausea, bitter taste), no erosions/ulcers on endoscopy, no structural obstruction.
- •First-Line Pharmacotherapy (3–6 months)
- Prokinetics: Domperidone (10 mg TID before meals) — $12–$18/month - Mucosal protectants: Sucralfate suspension (1g QID) — $20–$30/month - *Combined monthly drug cost*: $60–$90
- •Diagnostic & Monitoring Fees (Per Episode)
- Liver function panel (ALT, AST, GGT, ALP, total bilirubin) — $22 - Serum bile acid assay — $38 - Abdominal ultrasound (gallbladder, biliary tree, gastric motility) — $35
Surgical / Procedural Interventions
*Eligibility Criteria:* Refractory symptoms ≥12 months despite optimized medical therapy; documented pathological bile reflux (24-hr impedance-pH >10% bile exposure time); exclusion of PPI-responsive GERD or malignancy.
- •Laparoscopic Roux-en-Y Gastric Bypass (RYGB) – Primary surgical option
- Procedure (including OR time, laparoscopic instruments, surgeon/anesthesia fees) — $4,200–$5,800 - 3-day inpatient stay (standard ward) — $360 - Post-op endoscopy at 6 weeks — $185
- •Endoscopic Duodenal-Jejunal Bypass Sleeve (investigational, limited centers)
- Mandatory pre-op ERCP to rule out biliary stricture — $410
Special/Complex Condition Management
- •Post-Cholecystectomy Bile Reflux: Add Ursodeoxycholic acid (UDCA) 10–15 mg/kg/day — $25–$35/month
- •Concomitant Cirrhosis or Portal Hypertension: Requires hepatology co-management; transient elastography (FibroScan) — $75, variceal screening EGD — $185
- •Refractory Cases with Gastric Atrophy/Metaplasia: Annual surveillance EGD + targeted biopsies — $260/year
Quick Selection Guide
- •<45 years, mild symptoms, budget < $100/month: Start with domperidone + sucralfate + lifestyle modification ($72/month)
- •45–65 years, moderate-severe symptoms, comorbid diabetes/hypertension: Colestyramine + UDCA + endoscopic monitoring ($95/month + $220 baseline diagnostics)
- •>65 years, failed 12-month meds, no major cardiopulmonary disease: Laparoscopic RYGB ($4,900 total, all-inclusive)
- •Any age with decompensated liver disease or severe malnutrition: Medical optimization only; avoid surgery; prioritize UDCA + nutritional support ($60/month + dietitian consult $45/session)
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Bile reflux gastritis Medical Vacation Packages
Curated transparent all-inclusive packages combining Bile reflux gastritis treatment with China top medical destinations:
